Finance

Lists
DPHA:STO
Disruptive Pharma AB (publ)
SEK 1.47
+1.24%
(+0.018) 1D
Aug 20, 5:00:00 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for DPHA...
Open
SEK 1.45
High
SEK 1.50
Low
SEK 1.45
Mkt. cap
62.42M
Avg. vol.
17.12K
Volume
0.00
52-wk high
SEK 27.00
52-wk low
SEK 0.88
EPS
-SEK 4.08
Shares outstanding
44.59M
No. of employees
12
Open
SEK 1.45
High
SEK 1.50
Low
SEK 1.45
Mkt. cap
62.42M
Avg. vol.
17.12K
Volume
0.00
52-wk high
SEK 27.00
52-wk low
SEK 0.88
EPS
-SEK 4.08
Shares outstanding
44.59M
No. of employees
12
About Disruptive Pharma AB (publ)
CEOTobias L Agervald
Employees12
Founded1974
Headquarters-
SectorBiotechnology
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
23.15M
12.51M
3.87M
18.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.72M
3.49M
2.69M
4.48M
Operating expense
25.86M
16.00M
6.56M
4.51M
Total operating expenses
25.86M
16.00M
6.56M
4.51M
Operating income
-25.86M
-16.00M
-6.56M
-4.51M
Other non operating income
-
1.00K
-
147.00K
EBT including unusual items
-26.08M
-16.33M
-6.35M
-4.36M
EBT excluding unusual items
-26.08M
-16.33M
-6.35M
-4.36M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
16.00K
Net income
-26.08M
-16.33M
-6.35M
-4.36M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
150.00K
1.78M
168.00K
-
Interest expense
-470.00K
-
-
-
Net interest expenses
-320.00K
1.78M
168.00K
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps